Status:
UNKNOWN
Blood Biomarker Study to Diagnose Adolescent Sport Concussion
Lead Sponsor:
Neurolytixs
Conditions:
Brain Concussion
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
Concussions are one of the most complex conditions to manage in sport medicine due to the individualized clinical presentation, caused by a complex neurometabolic cascade, and the lack of a diagnostic...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent/assent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female athletes, aged 13-17 inclusive
Exclusion
- Individuals who have suffered a known concussion within the 6 months prior to enrollment
- Individuals who suffer from an acute neurological disorder
- Known pregnancy
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05287997
Start Date
June 1 2022
End Date
December 1 2023
Last Update
April 4 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Legacy Center Sports Complex
Brighton, Michigan, United States, 48116
2
The Hill Academy
Caledon, Ontario, Canada, L7K 1S7